Evidence map›Paper›PMID 21772061›Full record

ArticleBrain : a journal of neurology2011

Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition.

Olivia Engmann, Tibor Hortobágyi, Ruth Pidsley, Claire Troakes, Hans-Gert Bernstein, Michael R Kreutz, Jonathan Mill, Margareta Nikolic, Karl Peter Giese

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. WTAP-mediated mRedox report : communications in free radical research · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Olivia EngmannDepartment for Neuroscience, King’s College, London SE5 9NU, UK.
Tibor Hortobágyi
Ruth Pidsley
Claire Troakes
Hans-Gert Bernstein
Michael R Kreutz
Jonathan Mill
Margareta Nikolic
Karl Peter Giese
King's College London · GBHammersmith Hospital · GBLeibniz Institute for Neurobiology · DEUniversity Hospital Magdeburg · DE

Funding

Epigenetic Mechanisms of Memory StorageR01MH087463 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ABEL, EDWIN TED G. · 2010 to 2025
$7.8M
Medical Research Council G0600676Medical Research Council G0800393NIMH NIH HHS R01 MH087463NIMH NIH HHS R01-MH-087463-01A1
6 · The paper itself

Abstract

Cyclin-dependent kinase 5 is activated by small subunits, of which p35 is the most abundant. The functions of cyclin-dependent kinase 5 signalling in cognition and cognitive disorders remains unclear. Here, we show that in schizophrenia, a disorder associated with impaired cognition, p35 expression is reduced in relevant brain regions. Additionally, the expression of septin 7 and OPA1, proteins downstream of truncated p35, is decreased in schizophrenia. Mimicking a reduction of p35 in heterozygous knockout mice is associated with cognitive endophenotypes. Furthermore, a reduction of p35 in mice results in protein changes similar to schizophrenia post-mortem brain. Hence, heterozygous p35 knockout mice model both cognitive endophenotypes and molecular changes reminiscent of schizophrenia. These changes correlate with reduced acetylation of the histone deacetylase 1 target site H3K18 in mice. This site has previously been shown to be affected by truncated p35. By restoring H3K18 acetylation with the clinically used specific histone deacetylase 1 inhibitor MS-275 both cognitive and molecular endophenotypes of schizophrenia can be rescued in p35 heterozygous knockout mice. In summary, we suggest that reduced p35 expression in schizophrenia has an impact on synaptic protein expression and cognition and that these deficits can be rescued, at least in part, by the inhibition of histone deacetylase 1.

Indexed as

Acoustic StimulationAnalysis of VarianceAnimalsBenzamidesBrainCell Cycle ProteinsCognition DisordersEndophenotypesExploratory BehaviorFemaleGene Expression RegulationGTP PhosphohydrolasesHistone Deacetylase InhibitorsHumansInhibition, PsychologicalInterpersonal RelationsBenzamidesCdk5r1 protein, mouseCell Cycle ProteinsentinostatGTP PhosphohydrolasesHistone Deacetylase Inhibitorslysin, gastropodaMucoproteinsNerve Tissue Proteinsneuronal Cdk5 activator (p25-p35)OPA1 protein, humanPhosphotransferasesPyridinesSEPTIN7 protein, humanSeptins

Identifiers

PMID21772061
PMCPMC3155706
OpenAlexW2162583663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.